Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Heron Therapeutics (HRTX) Shares Issued: 2010-2025

Historic Shares Issued for Heron Therapeutics (HRTX) over the last 5 years, with Sep 2025 value amounting to $19.3 million.

  • Heron Therapeutics' Shares Issued was N/A to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.7 million, marking a year-over-year change of. This contributed to the annual value of $637,000 for FY2024, which is 97.86% down from last year.
  • Heron Therapeutics' Shares Issued amounted to $19.3 million in Q3 2025, which was up 4,066.88% from $462,000 recorded in Q4 2024.
  • In the past 5 years, Heron Therapeutics' Shares Issued registered a high of $74.4 million during Q3 2022, and its lowest value of -$18,000 during Q4 2022.
  • For the 3-year period, Heron Therapeutics' Shares Issued averaged around $16.3 million, with its median value being $19.3 million (2025).
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 75.20% in 2021, then plummeted by 102.95% in 2022.
  • Over the past 5 years, Heron Therapeutics' Shares Issued (Quarterly) stood at $610,000 in 2021, then crashed by 102.95% to -$18,000 in 2022, then slumped by 60.95% to $29.1 million in 2023, then reached $462,000 in 2024, then reached $19.3 million in 2025.
  • Its Shares Issued stands at $19.3 million for Q3 2025, versus $462,000 for Q4 2024 and $29.1 million for Q3 2023.